Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
From 1995 to 2016, hepatocellular carcinoma incidence in rural populations climbed by 218%.
An extra booster dose raised antibody levels in one third of people with organ transplants, but many remain unprotected.
Even lower levels of alcohol use by women puts them at a greater risk for several severe illnesses.
The early cancer is detected, the easier it is to treat.
Alcoholism-related liver disease was a growing problem even before COVID-19, but the pandemic has dramatically added to the toll.
People with advanced liver cirrhosis are at greater risk for severe COVID-19 illness and death.
Liver complications, heart disease and non-liver cancers also account for most deaths among people with hepatitis B or C.
Transplants due to hepatitis C have dropped dramatically, especially among people with liver cancer.
Hepatitis B and C, non-alcoholic steatohepatitis (NASH) and alcohol-related liver disease are the main causes of liver cancer and cirrhosis.
Better treatments for hepatitis B and C and a lack of such advances for fatty liver or alcoholic liver disease are driving outcomes.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.